These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22372200)

  • 1. Bone marrow disorders: recent advances, Part II. Introduction.
    Torlakovic EE; Porwit A; Butany J
    Semin Diagn Pathol; 2012 Feb; 29(1):1. PubMed ID: 22372200
    [No Abstract]   [Full Text] [Related]  

  • 2. Mastocytosis, MCAS, and Related Disorders-Diagnosis, Classification, and Therapy.
    Niedoszytko M; Valent P; Nedoszytko B
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34068468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The myeloproliferative neoplasms: insights into molecular pathogenesis and changes in WHO classification and criteria for diagnosis.
    Anastasi J
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):693-708. PubMed ID: 19577165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic evaluation and classification of mastocytosis.
    Valent P
    Immunol Allergy Clin North Am; 2006 Aug; 26(3):515-34. PubMed ID: 16931291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unusual hematologic malignancies. Case 1. Hematologic malignancy presenting with diarrhea and bony lesions: systemic mastocytosis.
    Tao J; Flaherty K; Bagg A
    J Clin Oncol; 2002 Sep; 20(17):3737-9. PubMed ID: 12202674
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathology of extramedullary mastocytosis.
    Doyle LA; Hornick JL
    Immunol Allergy Clin North Am; 2014 May; 34(2):323-39. PubMed ID: 24745677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
    Valent P; Sperr WR; Schwartz LB; Horny HP
    J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2016 updated WHO classification of lymphoid neoplasias.
    Quintanilla-Martinez L
    Hematol Oncol; 2017 Jun; 35 Suppl 1():37-45. PubMed ID: 28591427
    [No Abstract]   [Full Text] [Related]  

  • 9. 2016 WHO Classification update-What's new in lymphoid neoplasms.
    Hsi ED
    Int J Lab Hematol; 2017 May; 39 Suppl 1():14-22. PubMed ID: 28447410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis.
    Valent P; Sperr WR; Samorapoompichit P; Geissler K; Lechner K; Horny HP; Bennett JM
    Leuk Res; 2001 Jul; 25(7):595-602. PubMed ID: 11377685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the 2016 revised WHO criteria for myeloproliferative neoplasms, unclassifiable: Comparison with the 2008 version.
    Iurlo A; Gianelli U; Cattaneo D; Thiele J; Orazi A
    Am J Hematol; 2017 Apr; 92(4):E48-E51. PubMed ID: 28109016
    [No Abstract]   [Full Text] [Related]  

  • 12. Atypical myeloproliferative disorders in adults.
    Zachée P
    Transfus Apher Sci; 2011 Apr; 44(2):211-21. PubMed ID: 21402312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New era of laboratory testing. Topics: II. Particulars; 5. Laboratory testing which supports the treatment of hematological malignancies].
    Tohyama K
    Nihon Naika Gakkai Zasshi; 2013 Dec; 102(12):3140-6. PubMed ID: 24605562
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnosis and treatment of mast cell disorders: practical recommendations.
    Sandes AF; Medeiros RS; Rizzatti EG
    Sao Paulo Med J; 2013; 131(4):264-74. PubMed ID: 24141298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addressing the Challenges of Eosinophilia and Mastocytosis.
    Rimsza L; Craig FE; Reichard KK; Kelemen K; George TI; Horny HP; Orazi A; Quintanilla-Martinez L; Wang SA; King RL
    Am J Clin Pathol; 2021 Feb; 155(2):156-159. PubMed ID: 33367532
    [No Abstract]   [Full Text] [Related]  

  • 16. PD-L1 Expression in Mastocytosis.
    Williams M; Lidke DS; Hartmann K; George TI
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31086024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mastocytosis--diagnostic criteria and treatment].
    Dereń-Wagemann I; Kuliszkiewicz-Janus M; Kuliczkowski K
    Postepy Hig Med Dosw (Online); 2009 Nov; 63():564-76. PubMed ID: 20009120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic criteria and classification of mastocytosis in 2014.
    Akin C; Valent P
    Immunol Allergy Clin North Am; 2014 May; 34(2):207-18. PubMed ID: 24745670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoplastic hematopathology. Preface.
    Gascoyne RD
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):xi-xii. PubMed ID: 19577161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.